Immunovia AB
IMMNOV
株式のランク
#34421
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for... Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
株価
$0.00789665
時価総額
$5.31M
変化(1日)
2.90%
変化(1年)
-84.83%
国
SE
取引 Immunovia AB (IMMNOV)
カテゴリー
Healthcare
Immunovia AB(IMMNOV)の株価履歴
終値の最高値: $0.01 (2026-10-01)
終値の最安値: $6.16 (2019-06-01)
終値の最安値: $6.16 (2019-06-01)
Immunovia AB の株価履歴(2019 ~ 2026)
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2026 (TTM) | -50.09% |
| 2025 | -2.79% |
| 2024 | -50.93% |
| 2023 | -90.35% |
| 2022 | -60.80% |
| 2021 | -55.60% |
| 2020 | 0.32% |
| 2019 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $177.93 | 21.98% |
US
|